Accel Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 26, 2025, 10:28 am

Competitors of Accel Ltd

All Competitor Stocks of Accel Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:40 am

Below is a detailed analysis of the quarterly data for Accel Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 39.07 Cr.. The value appears to be declining and may need further review. It has decreased from 46.12 Cr. (Mar 2025) to 39.07 Cr., marking a decrease of 7.05 Cr..
• For Expenses, as of Jun 2025, the value is 35.91 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 42.55 Cr. (Mar 2025) to 35.91 Cr., marking a decrease of 6.64 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.16 Cr.. The value appears to be declining and may need further review. It has decreased from 3.57 Cr. (Mar 2025) to 3.16 Cr., marking a decrease of 0.41 Cr..
• For OPM %, as of Jun 2025, the value is 8.09%. The value appears strong and on an upward trend. It has increased from 7.74% (Mar 2025) to 8.09%, marking an increase of 0.35%.
• For Other Income, as of Jun 2025, the value is 1.77 Cr.. The value appears to be declining and may need further review. It has decreased from 1.91 Cr. (Mar 2025) to 1.77 Cr., marking a decrease of 0.14 Cr..
• For Interest, as of Jun 2025, the value is 1.65 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.15 Cr. (Mar 2025) to 1.65 Cr., marking a decrease of 0.50 Cr..
• For Depreciation, as of Jun 2025, the value is 1.67 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.69 Cr. (Mar 2025) to 1.67 Cr., marking a decrease of 0.02 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.61 Cr.. The value appears to be declining and may need further review. It has decreased from 1.64 Cr. (Mar 2025) to 1.61 Cr., marking a decrease of 0.03 Cr..
• For Tax %, as of Jun 2025, the value is 25.47%. The value appears to be improving (decreasing) as expected. It has decreased from 103.66% (Mar 2025) to 25.47%, marking a decrease of 78.19%.
• For Net Profit, as of Jun 2025, the value is 1.20 Cr.. The value appears strong and on an upward trend. It has increased from -0.08 Cr. (Mar 2025) to 1.20 Cr., marking an increase of 1.28 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.21. The value appears strong and on an upward trend. It has increased from -0.01 (Mar 2025) to 0.21, marking an increase of 0.22.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:04 am

Growth

Last Updated: September 5, 2025, 2:01 pm

Balance Sheet

Last Updated: October 10, 2025, 3:19 pm

Below is a detailed analysis of the balance sheet data for Accel Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 55.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Mar 2024) to 55.00 Cr., marking an increase of 1.00 Cr..
• For Borrowings, as of Mar 2025, the value is 64.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 74.00 Cr. (Mar 2024) to 64.00 Cr., marking a decrease of 10.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 54.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 51.00 Cr. (Mar 2024) to 54.00 Cr., marking an increase of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 185.00 Cr.. The value appears to be improving (decreasing). It has decreased from 190.00 Cr. (Mar 2024) to 185.00 Cr., marking a decrease of 5.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 82.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Mar 2024) to 82.00 Cr., marking a decrease of 9.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 95.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Mar 2024) to 95.00 Cr., marking an increase of 3.00 Cr..
• For Total Assets, as of Mar 2025, the value is 185.00 Cr.. The value appears to be declining and may need further review. It has decreased from 190.00 Cr. (Mar 2024) to 185.00 Cr., marking a decrease of 5.00 Cr..

However, the Borrowings (64.00 Cr.) are higher than the Reserves (55.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Accel Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 5. It has decreased from 0.57 (Mar 24) to 0.32, marking a decrease of 0.25.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 5. It has decreased from 0.57 (Mar 24) to 0.32, marking a decrease of 0.25.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 3. It has decreased from 1.73 (Mar 24) to 1.31, marking a decrease of 0.42.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 11.56. It has increased from 6.98 (Mar 24) to 11.56, marking an increase of 4.58.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 11.56. It has increased from 11.08 (Mar 24) to 11.56, marking an increase of 0.48.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 28.32. It has decreased from 29.02 (Mar 24) to 28.32, marking a decrease of 0.70.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 3.07. This value is within the healthy range. It has decreased from 3.26 (Mar 24) to 3.07, marking a decrease of 0.19.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.99. This value is within the healthy range. It has decreased from 2.06 (Mar 24) to 1.99, marking a decrease of 0.07.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.63. This value is within the healthy range. It has decreased from 0.73 (Mar 24) to 0.63, marking a decrease of 0.10.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 2. It has decreased from 0.53 (Mar 24) to 0.22, marking a decrease of 0.31.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 2. It has decreased from 0.57 (Mar 24) to 0.35, marking a decrease of 0.22.
• For PBDIT Margin (%), as of Mar 25, the value is 10.85. This value is within the healthy range. It has decreased from 11.22 (Mar 24) to 10.85, marking a decrease of 0.37.
• For PBIT Margin (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 10. It has decreased from 7.11 (Mar 24) to 7.03, marking a decrease of 0.08.
• For PBT Margin (%), as of Mar 25, the value is 2.23. This value is below the healthy minimum of 10. It has decreased from 2.52 (Mar 24) to 2.23, marking a decrease of 0.29.
• For Net Profit Margin (%), as of Mar 25, the value is 0.80. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.80, marking a decrease of 1.03.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.24. This value is below the healthy minimum of 8. It has decreased from 1.96 (Mar 24) to 1.24, marking a decrease of 0.72.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.06. This value is below the healthy minimum of 15. It has decreased from 7.89 (Mar 24) to 3.06, marking a decrease of 4.83.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.96. This value is below the healthy minimum of 10. It has increased from 9.61 (Mar 24) to 9.96, marking an increase of 0.35.
• For Return On Assets (%), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 5. It has decreased from 1.74 (Mar 24) to 1.11, marking a decrease of 0.63.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.57. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 0.57, marking a decrease of 0.54.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.89. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 0.89, marking a decrease of 0.71.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.87. It has decreased from 0.90 (Mar 24) to 0.87, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1.5. It has decreased from 1.02 (Mar 24) to 0.99, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 1. It has decreased from 0.90 (Mar 24) to 0.89, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 8.66 (Mar 24) to 0.00, marking a decrease of 8.66.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 52.49 (Mar 24) to 0.00, marking a decrease of 52.49.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 16.99 (Mar 24) to 0.00, marking a decrease of 16.99.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 47.51 (Mar 24) to 0.00, marking a decrease of 47.51.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 83.01 (Mar 24) to 0.00, marking a decrease of 83.01.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has decreased from 2.60 (Mar 24) to 2.26, marking a decrease of 0.34.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 3. It has decreased from 1.49 (Mar 24) to 1.17, marking a decrease of 0.32.
• For Enterprise Value (Cr.), as of Mar 25, the value is 140.97. It has decreased from 163.87 (Mar 24) to 140.97, marking a decrease of 22.90.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.86, marking a decrease of 0.12.
• For EV / EBITDA (X), as of Mar 25, the value is 7.97. This value is within the healthy range. It has decreased from 8.74 (Mar 24) to 7.97, marking a decrease of 0.77.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has decreased from 0.64 (Mar 24) to 0.52, marking a decrease of 0.12.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 47.50 (Mar 24) to 0.00, marking a decrease of 47.50.
• For Price / BV (X), as of Mar 25, the value is 1.28. This value is within the healthy range. It has decreased from 2.60 (Mar 24) to 1.28, marking a decrease of 1.32.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has decreased from 0.64 (Mar 24) to 0.52, marking a decrease of 0.12.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness